Blood test may spot liver cancer risk years early in cirrhosis patients
NCT ID NCT06778317
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a blood test that looks for a marker called mSEPT9 can predict liver cancer in people with cirrhosis. Researchers will follow 400 patients for up to 5 years, taking blood samples every 6 months to see if changes in this marker signal cancer risk. The goal is to catch liver cancer earlier and tailor screening to those who need it most.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mSEPT9 blood test
- What this could lead to
- If successful, this blood test could help doctors identify cirrhosis patients at highest risk for liver cancer, allowing for earlier detection and personalized monitoring.
- What could go wrong
- This is an observational study, not a treatment trial. The test may not accurately predict cancer in all patients, and results may not change outcomes. Further studies would be needed to confirm its usefulness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Regional and University Hospital Center of Nancy
RECRUITINGVandœuvre-lès-Nancy, 54511, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Could a vaccine help fight Hard-to-Treat cancers?
- Could a tailored diet before surgery boost liver cancer recovery?
- Can a new PET tracer light up hidden cancers?
- A new test could reveal how radiation affects the liver
- Can everyday drugs shield the liver from Cirrhosis's worst threats?